Skip Nav Destination
1-7 of 7
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Fuliang Chu, PhD, Jinsheng Weng, MD PhD, Shao-Qing Kuang, PhD, Xiaoyun Cheng, JingJing Cao, Jingwei Liu, MD, Swathi Karri, Adithi Reddy, Sattva S. Neelapu, MD
Blood (2018) 132 (Supplement 1): 1662.
Jinsheng Weng, MD PhD, Kelsey Moriarty, BD, Yong Pan, Man Chun John MA, PhD, Rohit Mathur, PhD, Zheng Zhang, Hiroki Torikai, MD, Sourindra N Maiti, Fuliang Chu, PhD, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J N Cooper, MD PhD, R. Eric Davis, MD, Sattva S. Neelapu, MD
Blood (2018) 132 (Supplement 1): 3488.
PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody
Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Celine Kerros, PhD, Anna Sergeeva, PhD, Amanda Cernosek, BS, Haroon Jakher, BS, Madhushree Zope, Rebecca Patenia, MS, Lisa St John, PhD, Alexander Perakis, BA, Karen Dwyer, PhD, Ken H. Young, MD PhD, Jinsheng Weng, PhD, Sijie Lu, PhD, Elizabeth A. Mittendorf, MD PhD, Larry W Kwak, MD PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD
Blood (2014) 124 (21): 2133.
Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy
Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Anna Sergeeva, PhD, Haroon Jakher, BS, Jinsheng Weng, Ph.D, Lisa S St. John, PhD, Kathryn Ruisaard, BS, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD
Blood (2012) 120 (21): 4973.
Jinsheng Weng, Seema Rawal, Fuliang Chu, Hyun Jun Park, Rakesh Sharma, David A. Delgado, Luis Fayad, Michelle Fanale, Jorge Romaguera, Amber Luong, Larry W. Kwak, Sattva S. Neelapu
Blood (2012) 120 (8): 1613–1623.
Includes: Supplemental data
Jinsheng Weng, Ph.D, Seema Rawal, PhD, Hyun Jun Park, Ph.D, Rakesh Sharma, Ph.D, Sattva S. Neelapu, MD
Blood (2011) 118 (21): 105.
Blood (2010) 116 (21): 3018.